DERM
USDJourney Medical Corporation Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$8.410
High
$9.010
Low
$8.260
Volume
0.22M
Company Fundamentals
Market Cap
236.8M
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.16M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory lesions of rosacea
Journey Medical Corporation to Participate in October 2025 Investor Conferences
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing
Related Stocks
ECAT
BlackRock ESG Capital Allocation Term Trust Common Shares of Beneficial Interest
ROIC
Retail Opportunity Investments Corp. (MD)
FND
Floor & Decor Holdings Inc.
HBANM
Huntington Bancshares Incorporated Depositary Shares each representing a 1/1000th interest in a share of Huntington Series I Preferred Stock
MPLN
MultiPlan Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.